| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443197 | European Journal of Cancer | 2014 | 9 Pages |
Abstract
Low-dose AA or prior KT treatment were not associated with poorer outcome in men with mCRPC treated with AA. These observations may have implications for drug sequencing and dose in resource-limited settings.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Raya Leibowitz-Amit, Jo-An Seah, Eshetu G. Atenafu, Arnoud J. Templeton, Francisco E. Vera-Badillo, Nimira Alimohamed, Jennifer J. Knox, Ian F. Tannock, Srikala S. Sridhar, Anthony M. Joshua,